(20877828), K. S. S., (21233329), H. S. S., (21233332), J. R. G., (21233335), J. T. E., (21233338), S. M., (21233341), J. F., . . . (21233347), E. R. H. (2025). Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas.
Chicago Style (17th ed.) Citation(20877828), Kimberley S. Samkoe, et al. Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide That Targets EGFR, Applied to Soft-Tissue Sarcomas. 2025.
MLA (9th ed.) Citation(20877828), Kimberley S. Samkoe, et al. Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide That Targets EGFR, Applied to Soft-Tissue Sarcomas. 2025.
Warning: These citations may not always be 100% accurate.